E-poster No. / 壁報編號
C64
Title / 題目
Real-World Effectiveness and Safety of Neoadjuvant Pembrolizumab plus Chemotherapy in Early-Stage Triple-Negative Breast Cancer: Updated Data from a Single-Center Taiwanese Cohort
First Author / 第一作者
Han Fang Cheng
Institution / 單位
1Comprehensive Breast Health Center, Department of Surgery, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC.
2School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan, ROC.
Audio / 音訊檔
Author Group / 作者群
Yi‐Fang Tsai1,2, Chun‐Yu Liu1,2,3, Chih‐Yi Hsu1,2,4, Pei‐Ju Lien1,5, Yen‐Shu Lin1,2, Ta‐Chung Chao1,2,3, Jiun‐I. Lai1,3,6, Yen‐Jen Chen1,2, Bo‐Fang Chen1,2, Jen‐Hwey Chiu1,2,7,8, Ling‐Ming Tseng1,2*, Chi‐Cheng Huang1,9*
Author Group Institution/ 作者群單位
1Comprehensive Breast Health Center, Department of Surgery, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC.
2School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan, ROC.
3Division of Medical Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC.
4Department of Pathology and Laboratory Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC.
5Department of Nurse, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC.
6Institute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan, ROC.
7Center for Traditional Medicine, Taipei Veterans General Hospital, Taipei City, Taiwan, ROC.
8Institute of Traditional Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei City, Taiwan, ROC.
9Institute of Epidemiology and Preventive Medicine, College of Medicine, National Taiwan University, Taipei City, Taiwan, ROC.
*Corresponding authors
Category / 主題分類
Clinical Research
Keyword / 關鍵字
TNBC, immunotherapy, immune-related adverse effect, real-world data